Quantifying the effects of single mutations on viral escape from broad and narrow antibodies to an H1 influenza hemagglutinin
Abstract
Influenza virus can completely escape most antibodies with single mutations. However, rare antibodies broadly neutralize many viral strains. It is unclear how easily influenza virus might escape such antibodies if it was under strong pressure to do so. Here we map all single amino-acid mutations that increase resistance to broad antibodies targeting an H1 hemagglutinin. Crucially, our approach not only identifies antigenic mutations but also quantifies their effect sizes. All antibodies select mutations, but the effect sizes vary widely. The virus can escape a broad antibody that targets residues in hemagglutinins receptor-binding site the same way it escapes narrow strain-specific antibodies: via single mutations with huge effects. In contrast, broad antibodies targeting hemagglutinins stalk only select mutations with small effects. Therefore, among the antibodies we have examined, breadth is an imperfect indicator of the potential for viral escape via single mutations. Broadly neutralizing antibodies targeting the H1 hemagglutinin stalk are quantifiably harder to escape than the other antibodies tested here.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Complete mapping of viral escape from neutralizing antibodies
M. B. Doud, S. E. Hensley, J. D. Bloom·bioRxiv·Nov 9, 2016
- Sera from individuals with narrowly focused influenza virus antibodies rapidly select viral escape mutations in ovo
A. K. F. Davis, K. McCormick, … S. E. Hensley·bioRxiv·May 17, 2018
- Influenza H3 and H1 hemagglutinins have different genetic barriers for resistance to broadly neutralizing stem antibodies
N. C. Wu, A. J. Thompson, … I. A. Wilson·bioRxiv·Dec 30, 2019
- Antibody neutralization of an influenza virus that uses neuraminidase for receptor binding
L. E. Gentles, H. Wan, … J. D. Bloom·bioRxiv·May 8, 2020
- Novel epitopes of human monoclonal antibodies targeting the influenza virus N1 neuraminidase
E. Kirkpatrick Roubidoux, M. McMahon, … F. Krammer·bioRxiv·Feb 26, 2021
- Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies
C.-Y. Lee, C. J. Caceres, … A. C. Lowen·bioRxiv·Jul 14, 2022